Skip to main content
. 2010 Jan 19;7(1):e1000179. doi: 10.1371/journal.pmed.1000179

Table 1. Evolution of institutional arrangements for malaria R&D.

Phase Purpose of R&D Institutions Targeted End-Users Funding Targeted Diseases
I: Late Nineteenth Century through the 1950s National public goods Industrialized countries Public, private Malaria, yellow fever
II: 1960s–80s International health programs (e.g., TDR, Fogarty International Center, Rockefeller Foundation) Developing countries Public, philanthropic Malaria and other tropical infectious diseases
III: 1990s–2000s Global health partnerships neglected disease R&D (e.g., PDPs) Developing countries Public, philanthropic, private sector Malaria, tuberculosis, HIV/AIDS and neglected tropical infectious diseases
IV: The Future Global public goods for global health Global Public, philanthropic, private sector All types